Dr. Hyung Dong Park, MD

Dr. Park practices at Good Samaritan Hospital in Suffern, New York, part of Westchester Medical Center Health Network.

Dr. Park's NPI, 1659418382, was assigned on January 31, 2007. Dr. Park holds New York license 285118.

Dr. Park's primary practice is Good Samaritan Hospital, at 255 Lafayette Avenue, Suffern, NY 10901 in Rockland County. The practice phone is (914) 368-5000. The NPI Registry lists Dr. Park's practice address as 241 North Rd, Poughkeepsie, NY 12601.

Dr. Park's primary practice is Good Samaritan Hospital in Suffern, New York, part of Westchester Medical Center Health Network. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Park to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Park practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Park's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Park's licenses on file in 4 states: New York, North Carolina, Oregon and Washington.

CMS data shows 303 Medicare services from Dr. Park across 5 procedure codes in 2024, for 112 Medicare patients. Medicare paid $24,174 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 112 Medicare patients who saw Dr. Park in 2024. The largest group is 75 to 84, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Park's median patient age at 65, with 50% women.

In 2024, Dr. Park wrote 73 Medicare Part D claims for 39 patients. 92% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $103 in total drug cost. In 2023, CMS named 48 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Park for performance year 2024, reported as part of a group. Dr. Park accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Park from 2 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $25.